SB 2009 Hawaii Senate · 2020 Regular Session

RELATING TO HEALTH.

Summary

Places a cap on the total amount that an insured is required to pay for an in-network purchase of a prescription insulin drug covered under a health benefit plan's formulary at $100 per thirty-day supply of that drug. Clarifies existing drug benefit and therefore is exempt from the impact assessment report. Effective 7/1/2050. (SD1)

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2020

Committee Review

Floor Vote

Governor

Introduced Jan 9, 2020 Last action Feb 14, 2020

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 14, 2020

Committee

Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.

upper

Feb 14, 2020

Committee

Reported from CPH (Stand. Com. Rep. No. 2705) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.

upper

Jan 28, 2020

Upper · Passed

The committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 6 Aye(s): Senator(s) Baker, S. Chang, Ruderman, L. Thielen, Wakai, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Nishihara.

upper

Jan 24, 2020

Upper · Passed

The committee(s) on CPH has scheduled a public hearing on 01-28-20 9:00AM in conference room 229.

upper

Jan 15, 2020

Committee

Referred to CPH, WAM.

upper

Jan 15, 2020

Introduced

Introduced and passed First Reading.

upper

Jan 9, 2020

Introduced

Pending Introduction.

upper

3 primary · 0 co-sponsors